“We just don’t have the space for it”: Geographies of survival and spatial triage in overdose prevention sites
Olding M, Boyd J, Kerr T, McNeil R., Health Place. 2023
RE: Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada
Elefante J, Nolan S, Bach P, CMAJ, 2023
Associations of methadone and buprenorphine-naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription-type opioid use disorders: Exploratory analyses of the OPTIMA study
Bakouni H, McAnulty C, Tatar O, Socias ME, Le Foll B, Lim R, Ahamad K, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse., Am J Addict. 2023
Decriminalization thresholds for drug possession: A multi-criteria policy analysis framework
McAdam E, Small W, Mullins G, Graham B, Greer A, Winder N, DeBeck K., Int J Drug Policy. 2023
Police seizure of drugs without arrest among people who use drugs in Vancouver, Canada, before provincial ‘decriminalization’ of simple possession: a cohort study
Hayashi K, Singh Kelsall T, Shane C, Cui Z; Vancouver Area Network of Drug Users; Milloy MJ, DeBeck K, Kerr T., Harm Reduct J. 2023
Rating versus ranking in a Delphi survey: a randomized controlled trial
Del Grande C., Kaczorowski J., Trials, 2023
Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002–17
Larney S., Jones N.R., Hickman M., Nielsen S., Ali R., Degenhardt L., Addiction, 2023
Personality-specific pathways from bullying victimization to adolescent alcohol use: a multilevel longitudinal moderated mediation analysis
Laroque F.M., Boers E., Afzali M.H., Conrod P.J., Development and Psychopathology, 2023
Personality-specific pathways from bullying victimization to adolescent alcohol use: a multilevel longitudinal moderated mediation analysis
Laroque FM, Boers E, Afzali MH, Conrod PJ., Development and Psychopathology, 2023
Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis
Karamouzian M, Rafat B, Kolla G, Urbanoski K, Atkinson K, Bardwell G, Bonn M, Touesnard N, Henderson N, Bowles J, Boyd J, Brunelle C, Eeuwes J, Fikowski J, Gomes T, Guta A, Hyshka E, Ivsins A, Kennedy MC, Laurence G, Martignetti L, Nafeh F, Salters K, Tu D, Strike C, Pauly B, Werb D. Int J Drug Policy. 2023
